longer duration of delirium among patients with critical illness is predictive of mortality, longer hospital stay, greater health care costs, long-term cognitive impairment, and disability in activities of daily living. [1] [2] [3] [4] [5] [6] [7] [8] Delirium affects 2 of 3 patients with critical illness; however, these patients can also demonstrate acute brain dysfunction that does not meet the formal criteria for delirium when a validated delirium screening tool is used. This intermediate state of brain dysfunction is known as subsyndromal delirium (SSD). [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] Previous studies in patients with acute and critical illness have shown SSD to be associated with worse clinical outcomes. 10, [12] [13] [14] 18, 23 In these studies, however, patients were categorized into mutually exclusive groups according to their worst mental status (ie, coma, delirium, SSD, or normal), thereby ignoring fluctuations in mental status that are characteristic of delirium. Moreover, researchers in these studies did not assess the effect of SSD duration on clinical outcomes while also considering the effect of delirium. Therefore, because patients may experience both delirium and SSD during critical illness, these limitations may result in underestimates of the true prevalence of SSD and, thus, prior studies do not provide data on the outcomes independently associated with SSD duration.
To address these knowledge gaps, we characterized the prevalence and duration of SSD in patients who were hospitalized for critical illness and evaluated the independent association between duration of SSD and institutionalization. We hypothesized that SSD would have a high prevalence and that a longer SSD duration would be a predictor of discharge to an institution. To test these hypotheses, we performed this investigation, which was conceived a priori as part of the multicenter Bringing to Light the Risk Factors and Incidence of Neuropsychological Dysfunction in Intensive Care Unit Survivors (BRAIN-ICU) prospective cohort study. 5 
Materials and Methods

Study Design and Participants
Complete inclusion and exclusion criteria for the BRAIN-ICU study are reported elsewhere. 5 Briefly, we enrolled patients treated for respiratory failure or shock in the medical or surgical intensive care units (ICUs) at Vanderbilt University Medical Center and Saint Thomas Hospital in Nashville, Tennessee. We excluded patients with severe dementia, recent ICU exposure, those in whom delirium could not be assessed, and those in whom follow-up would be difficult owing to active substance abuse or residence more than 200 miles from Nashville. Patients or their proxies provided informed consent. The institutional review boards of the participating centers approved the investigation. All data were prospectively collected.
Defining Subsyndromal Delirium
We used the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) 24, 25 to assess all
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Subsyndromal delirium was considered present if the CAM-ICU assessment was negative but the patient showed at least 1 CAM-ICU feature.
noncomatose patients for delirium twice each day while they were in the ICU and once per day thereafter until hospital discharge (or for up to 30 days). Delirium was considered present when the CAM-ICU assessment was positive. SSD was considered present if the CAM-ICU assessment was negative but the patient demonstrated at least 1 CAM-ICU feature ( Figure 1 ). [9] [10] [11] 16, 20, 26 The primary exposure variable was SSD duration, defined as the number of days with SSD. To determine the presence of SSD and delirium, we considered all assessments with abnormal CAM-ICU features regardless of the potential underlying cause (eg, sedative-associated delirium). We chose this conservative and inclusive approach for 3 reasons: first, to our knowledge, data do not exist to suggest that any specific underlying cause of delirium features is unimportant for our outcome of interest. Second, it avoids any attempt to claim outright knowledge of the cause of a particular patient's delirium features. Third, if sedative-associated delirium features are not associated with institutionalization, then their inclusion would result in an underestimation of the true association between the duration of SSD and institutionalization.
Outcomes and Covariates
We defined institutionalization as discharge to a location other than the patient's home. These locations included rehabilitation hospitals, long-term acute care hospitals, nursing homes, hospice care, or other locations. We selected all covariates a priori. We included age, years of education, preillness cognitive status via the Informant Questionnaire on Cognitive Decline in the Elderly, 27 preillness disability status via the Katz Index of Activities of Daily Living, 28 medical comorbidities via the Charlson comorbidity index, 29 severity of illness via the mean daily modified Sequential Organ Failure Assessment score, 30, 31 delirium duration defined as the number of days that the CAM-ICU assessment was positive, duration of coma defined as the number of days the score on the Richmond Agitation Sedation Scale was -4 or -5, 32, 33 duration of severe sepsis, mean daily doses of benzodiazepines in midazolam equivalents, mean daily dose of propofol, and mean daily doses of opioids in fentanyl equivalents.
We also hypothesized that delirium duration may modify the potential association between SSD and institutionalization. Therefore, we included an interaction term between SSD duration and delirium duration in our statistical models.
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Figure 1
Assessing subsyndromal delirium (SSD) using the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) framework. SSD was assessed twice each day while patients were in the ICU and daily thereafter. At each assessment, each of the 4 CAM-ICU features were assessed. According to the CAM-ICU framework, if a patient demonstrated an acute change in mental status or a fluctuating course of mental status (feature 1) and inattention (feature 2) plus either altered consciousness (feature 3) or disorganized thinking (feature 4), the CAM-ICU was considered positive and delirium was present (dark blue box). If the CAM-ICU was negative, but the patient exhibited any of the CAM-ICU features, SSD was considered present (light blue box). Only if no CAM-ICU features were present was the patient considered to have normal mental status (white box). 
Missing Data
To reduce potential bias due to missing or incomplete data, and to allow us to calculate the duration of SSD without assuming normal status in cases of missing delirium features, 34 we used single imputation for any missing CAM-ICU features, using data from the assessments closest to the incomplete assessment.
Statistical Analysis
We used multiple logistic regression to determine the relationship between duration of SSD and institutionalization. Continuous covariates were allowed to be nonlinear by using restricted cubic splines. Nonlinear and interaction terms were excluded from the models if the global P value was greater than .20. We used R (version 3.1.0; https://www.r-project .org/) for all analyses. P less than .05 was considered statistically significant.
Results
We included 821 patients (median age, 61 years [interquartile range, 51-71 years]) with a high severity of illness ( Table 1 ). The majority of these patients were treated with sedatives and/or opiates at some point during their critical illness (Table 2-available online only, at www.ajcconline.org). Of the 636 patients who survived the index hospitalization, 281 (44%) were discharged to an institution; specifically, 135 (21%) were discharged to a rehabilitation facility, 57 (9%) to a long-term acute care hospital, 56 (9%) to a nursing home, 25 (4%) to hospice care, 6 (1%) to another hospital, and 2 (1%) to other locations.
Prevalence and Characteristics of Subsyndromal Delirium
At some point during the study, 702 patients (86%) had SSD lasting a median of 3 days (interquartile range, 2-5 days). Of these, 531 patients (76%) were also delirious during the study. There were 72 of the 821 patients (9%) who had delirium but did not have SSD during the study.
Of the 19 995 mental status assessments performed during the study, SSD was present in 29% (Table 3) , delirium was present in 26%, coma was present in 20%, and normal mental status (ie, no SSD, delirium, or coma) was present in 26%. The individual delirium features present during CAM-ICU assessments are presented in Table 3 . Single imputation was used in 4331 (22%) of all individual mental status assessments but did not result in a substantial reclassification of mental status assessments (Table 4 -available online only, at www.ajcconline.org).
The most common pattern of SSD was an acute change from baseline or fluctuation in mental status alone (CAM-ICU feature 1), which was present in 50% of assessments (Table 3) . Inattention (CAM-ICU feature 2), a cardinal feature of the full delirium syndrome, 16 was present in 473 assessments (8%). 325 (51) 413 (65) 12 (12-14) 2 (1-4) 25 (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) 9 (7) (8) (9) (10) (11) (12) 39 (6) 183 (29) 424 (67) 5 (2-9) 478 (75) 4 (2-7) 313 (49) 2 (1-5) 571 (90) 2 ( 420 (51) 559 (68) 12 (12-14) 2 (1-4) 25 (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) 9 (7) (8) (9) (10) (11) (12) 51 (6) 229 (28) 572 (70) 
Characteristic
Duration of Subsyndromal Delirium and Institutionalization
After adjusting for the potential confounders listed in the Methods, the number of days of SSD was an independent predictor of increased odds of institutionalization (P = .007). A sensitivity analysis that included mental status assessments with complete data as the exposure variable also indicated that SSD duration had an independent association with increased odds of discharge to an institution (P = .004).
Our model showed a significant interaction between the duration of SSD and duration of delirium (P for interaction = .01), indicating that how long a patient had delirium affected the strength and/or the direction of the association between the duration of SSD and institutionalization. Therefore, we present the associations between the duration of SSD and institutionalization for patients who experienced 4 different durations of delirium ( Figure 2 ). The strength of the independent association between the duration of SSD and institutionalization was greatest among those with the fewest days of delirium (Table 5) .
To place the independent effect of the duration of SSD on the odds of institutionalization into clinical context and to understand better the meaning of the statistical interaction term, we contrasted the effect of SSD duration on institutionalization in patients who never became delirious during the study with the effect of SSD duration in patients who also experienced 6 days of delirium (ie, the upper interquartile range for delirium duration). In a comparison of 2 typical patients neither of whom had delirium and who were alike in all other ways (ie, with all other covariate values adjusted to the median or mode), the patient who had SSD for 5 days was 4.2 times more likely to be discharged to an institution than the patient who had SSD for 1.5 days (Table 5) . Conversely, in a similar comparison among 2 typical patients who both experienced 6 days of delirium, the odds of institutionalization did not differ, regardless of the SSD duration (Table 5) .
Discussion
In this large, multicenter cohort investigation conducted in a diverse population of patients with critical illness (20 000 patient evaluations in > 800 patients), SSD (ie, the presence of delirium features that did not fulfill the diagnostic criteria for delirium) was present in more than 80% of patients at some point during their ICU stay. Although the prevalence of SSD was high, the degree to which patients were affected varied, as demonstrated by wide-ranging durations of SSD. SSD developed in 1 out of 4 patients in whom delirium never developed. Conversely, among patients who had delirium, 9 out of 10 also had at least 1 day of SSD.
Duration of SSD was independently associated with institutionalization, even after adjustment for several a priori selected confounders, including the number of days a patient was delirious. This association was strongest among patients with the fewest days of delirium (Figure 2 ). Unlike the full syndrome of delirium, routine screening for SSD is not performed in many ICUs; therefore, these data indicate 5025 (30) 2549 (51) 1053 (21) 349 (7) 256 (5) 250 (5) 218 (4) 152 (3) 117 (2) 81 (2) 4272 (26) 2815 (66) 921 (22) 320 (7) 216 (5) 2594 (15) 5164 (26) 5728 (29) 2877 (50) 1243 (22) 397 (7) 321 (6) 283 (5) 225 (4) 166 (3) 125 (2) 91 (2) 5165 (26) 3454 (67) 1057 (20) 391 (8) 263 (5) 3938 ( (Figure 1 ). Patients were considered to be comatose if their score on the Richmond Agitation-Sedation Scale was -4 or -5. Noncomatose patients were considered to have "normal" mental status if none of the CAM-ICU features were present. b Percentages may not total 100% because of rounding. Overall n reflects mental status assessments using single imputation. c "Other" combinations of subsyndromal delirium each occurred in <1% of assessments and included features 2 and 3; features 2 and 4; features 3 and 4; and features 2, 3, and 4. d CAM-ICU raters entered data on individual features and an overall CAM-ICU score. The CAM-ICU feature data were used to determine the CAM-ICU rating according to conventional CAM-ICU scoring. If a CAM-ICU feature was missing, we used the overall score to determine CAM-ICU rating. For example, if a patient was positive for features 1 and 4 and feature 2 was missing, but the overall CAM-ICU score was entered as "positive," that assessment was considered positive for delirium. Alternatively, for the same scenario, if the CAM-ICU score was "negative," then that assessment was considered negative for delirium but positive for subsyndromal delirium.
www.ajcconline.org greater odds of institutionalization in the type of patient in whom acute brain dysfunction is overlooked. These findings are of particular importance to bedside ICU nurses as the clinicians who assess for delirium with greatest frequency, because they suggest that patients with critical illness should be reported as having SSD when some CAM-ICU features are positive, even though the CAM-ICU assessment is negative. Thus, nurses would report that a patient with an abnormal assessment is in SSD, delirium, or coma-3 tiers of acute brain dysfunction. Additionally, future trials aimed at reducing delirium in patients with critical illness should assess effects on SSD. SSD was present in one-third of all mental status assessments, and most SSD-positive assessments were characterized by an acute change or fluctuating course of mental status (ie, CAM-ICU feature 1). This finding has important implications for the conduct of routine delirium screening. The CAM-ICU training manual refers to assessing those features "needed to get your answer." 35 For example, if feature 1 is absent, it is not necessary to assess features 2, 3, or 4, because the patient cannot have delirium. 35 Our data indicate, however, that stopping the CAM-ICU assessment at feature 1 will fail to detect 10% of SSD. Thus, consideration should be given to screening for all 4 CAM-ICU features. Moreover, our findings that CAM-ICU feature 1 was present in almost all SSD-positive assessments and that the duration of SSD is of prognostic importance suggest that efforts to maintain baseline mental status through strategies such as those designed to minimize exposure to psychoactive medications (eg, targeting light levels of sedation, 36, 37 spontaneous Figure 2 The relationship between the duration of subsyndromal delirium and odds of institutionalization stratified by the duration of delirium. The overall association between duration of subsyndromal delirium (SSD) and adjusted probability of institutionalization was significant (P = .007). We hypothesized a priori that this association would be modified by the delirium duration and found this interaction to be significant (P = .01), indicating a greater independent risk of disability from SSD in patients with shorter durations of overt delirium. Therefore, we present the association stratified by delirium duration. The panels display the step-wise reduction in the strength of the association among patients with 0 days of delirium (no delirium), 1 day of delirium (25th percentile), 2 days of delirium (50th percentile), and 6 days of delirium (75th percentile), respectively, with all other covariates adjusted to their respective median or mode. Red lines represent the independent association and shading represents the 95% confidence intervals. The overall association between the duration of SSD using the upper and lower interquartile ranges (IQRs, as boundaries by which to view this relationship) and the adjusted odds of institutionalization (ie, survival and discharge to rehabilitation hospital, long-term acute care hospital, nursing home, or hospice care) was significant (P = .007). This association was modified by the delirium duration (P for interaction = .01); therefore, we present odds ratios for the association between the duration of SSD and institutionalization for different delirium durations. The associations between the duration of SSD and the adjusted odds of institutionalization, at various durations of delirium, are presented graphically in Figure 2 . b Durations of delirium represent the IQRs for delirium duration: no delirium (0 days), the 25th percentile of duration of delirium (1 day), the 50th percentile of delirium duration (2 days), and the 75th percentile of delirium duration (6 days). c The 25th percentile of the duration of SSD. d The 75th percentile of the duration of SSD. e Adjusted odds ratios (95% CI) when patients with a duration of SSD at the 75th percentile are compared with patients with an SSD duration in the 25th percentile (reference), controlling for age, education, preillness cognitive function and disability status, comorbid medical conditions, severity of illness, the durations of delirium, coma, and severe sepsis, as well as mean daily doses of sedatives and opiates. For example, among patients who never had delirium, the odds of institutionalization among those with 5 days of SSD were 4.2 times greater than those in whom delirium never developed but who had 1.5 days of SSD, with all other covariates held constant.
awakening trials, 38, 39 or use of protocols of "no" sedation 40 ) may be a way to improve outcomes. Our approach to detect SSD with the CAM-ICU used previous definitions, [9] [10] [11] 14, [19] [20] [21] [22] 26, 41, 42 including the Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) classification for attenuated delirium syndrome (a synonym for SSD), 16 to classify those patients with delirium symptoms who did not meet the diagnostic criteria for full delirium as having SSD. We then considered the effect of the overall number of days a patient had SSD on outcomes, while also considering the number of days a patient had coma and delirium. By considering mental status each day, on a fluctuating basis, compared with a single ever/never status, our analysis better resembles the real-life clinical scenarios of patients with delirium and avoids potential bias resulting from classifying patients according to a single mental status for all study days, regardless of how many days it was present. Our inclusive approach yielded a prevalence of SSD of 86%, greater than the 33% reported in a previous study of SSD in patients with critical illness, 14 and greater than previous studies [10] [11] [12] [13] [14] 18, [21] [22] [23] 26, [43] [44] [45] in patients without critical illness, in which 16% to 51% of patients were found to have SSD.
Applying a more restrictive definition of SSD that classified patients according to a single mental status (ie, considering those who ever had delirium as delirious, regardless of whether they also had SSD) to the current cohort resulted in a prevalence of SSD of 21%. Nevertheless, we found that 9 out of 10 patients who would be classified as "delirious" using the restrictive approach also experienced at least 1 day of SSD. These data suggest the overall duration of delirium and SSD during critical illness may be underestimated when the time-fixed, more restrictive classification of mental status is used. Because the SSD duration was an important independent predictor of institutionalization in most patients with delirium, our findings advance the understanding of the prognostic significance of SSD.
In addition to considering all days of acute brain dysfunction as having potential importance, 2 other methodological advancements were made in our study of SSD during critical illness. First, whereas previous investigators have used a variety of dimensional (ie, Delirium Rating Scale Revised-98 11, 21, 22 ; Neelon and Champagne Confusion Scale ; and the Intensive Care Delirium Screening Checklist 14 ) or categorical delirium screening tools (ie, Confusion Assessment Method 9, 10, 12, 13, 15, 20, 23, 26, 45 ) to detect SSD, our study is, to our knowledge, the first to use the CAM-ICU. Second, in a manner complementing the previous studies of SSD patients with critical illness, 14, 43 we considered the presence of delirium symptoms to indicate either delirium (if the CAM-ICU assessment was positive) or SSD (if the CAM-ICU assessment was negative) even in the setting of sedation, because such medications may have important implications in most patients. 46, 47 To our knowledge, this is the first study of patients with critical illness to use multivariable analysis to show that SSD duration is an independent predictor of institutionalization. These findings build on those of Ouimet et al, 14 who observed a similar relationship in patients with SSD during critical illness but did not consider SSD duration or adjust for potential confounders, and those of Levkoff et al 18 and Bourdel-Marchasson et al, 12 who found an independent association between the presence of SSD and institutionalization after hospitalization for acute, but noncritical, illness. Thus, all these studies taken together have important clinical implications about how we as a critical-care community should start to consider SSD, a mental status overlooked in routine clinical practice.
Strengths of this investigation include enrollment of many patients with a wide range of critical illness diagnoses from the medical and surgical ICUs at 2 tertiary referral centers. In addition, we collected detailed physiologic and pharmacologic data, including twice-daily delirium assessments conducted by experienced research personnel using a well-validated delirium assessment tool, the CAM-ICU. We also considered the spectrum of acute brain dysfunction in our models by including durations of coma, delirium, and SSD. Next, those who conducted the follow-up assessments were masked to the details of each patient's ICU course, and clinicians who determined discharge disposition were unaware of formal delirium assessments. Finally, we used a conservative approach to determine the exposure to SSD and delirium. We considered each delirium feature to have the potential for harm, regardless of potential underlying cause of the delirium (eg, sedation-associated delirium). A small but important subset (ie, 12%) of patients with delirium while receiving sedating medications may resolve their Delirium symptoms, even when they do not meet full diagnostic criteria, should prompt clinicians to evaluate and address risk factors for delirium.
www.ajcconline.org symptoms after interruption of sedation. 46, 47 The inclusion of all patients regardless of whether they were receiving sedation is a strength of this investigation because the positive findings mean that, if anything, we may have underestimated the prognostic value of SSD. This investigation has some limitations. First, although the CAM-ICU detects 4 key features of delirium, at the time of this investigation, it had not been validated as a formal severity scoring system. 48 Studies by Trzepacz et al 21 and Meagher et al 22 that assessed for a wide array of delirium symptoms reported similar symptom profiles between delirium and SSD. 21, 22 Second, although our definition of SSD is in keeping with those from both of those studies and the Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition), there is no standard definition of SSD. Studies are needed to determine the specific delirium symptoms that may drive worse outcomes for patients and would be important in the development of a standardized SSD definition. Third, we did not collect data on residence in an institution before critical illness developed, which may have biased our results. Nevertheless, we enrolled a cohort of young patients with few preillness comorbid medical conditions and disabilities and excluded those with known or probable dementia. Finally, as with all studies of patients with emergent illnesses, we were unable to assess the trajectory of preillness cognition and disability status, given the unplanned nature of critical illness. 49 Nevertheless, we used well-validated and robust proxy-based tools to determine preillness cognition and disability status, and we included these important predictors of post-ICU functioning in our multivariable regression models. 5, 27, 28 Conclusions SSD was pervasive among patients with critical illness and is a strong independent predictor of institutionalization (ie, discharge to a location other than home). The duration of this intermediate form of acute brain dysfunction was more predictive of institutionalization in patients who had fewer days of delirium. Building on earlier studies, these data add to the literature. Because ICU nurses are the clinicians who screen for delirium with greatest frequency, standardized nursing assessment and reporting of SSD are indicated. Given the prognostic implications of SSD, the presence of delirium symptoms, even when they do not meet full diagnostic criteria, should prompt all ICU clinicians to evaluate and address modifiable delirium risk factors.
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